ZA891113B - Tetrazole excitatory amino acid receptor antagonists - Google Patents

Tetrazole excitatory amino acid receptor antagonists

Info

Publication number
ZA891113B
ZA891113B ZA891113A ZA891113A ZA891113B ZA 891113 B ZA891113 B ZA 891113B ZA 891113 A ZA891113 A ZA 891113A ZA 891113 A ZA891113 A ZA 891113A ZA 891113 B ZA891113 B ZA 891113B
Authority
ZA
South Africa
Prior art keywords
amino acid
receptor antagonists
acid receptor
tetrazole
excitatory amino
Prior art date
Application number
ZA891113A
Other languages
English (en)
Inventor
Paul Leslie Ornstein
Leslie Ornstein Paul
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA891113B publication Critical patent/ZA891113B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA891113A 1988-02-19 1989-02-13 Tetrazole excitatory amino acid receptor antagonists ZA891113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15776088A 1988-02-19 1988-02-19

Publications (1)

Publication Number Publication Date
ZA891113B true ZA891113B (en) 1990-10-31

Family

ID=22565157

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA891113A ZA891113B (en) 1988-02-19 1989-02-13 Tetrazole excitatory amino acid receptor antagonists

Country Status (18)

Country Link
EP (1) EP0330353B1 (fr)
JP (1) JPH01249767A (fr)
CN (1) CN1022244C (fr)
AT (1) ATE87918T1 (fr)
AU (1) AU608692B2 (fr)
CA (1) CA1332239C (fr)
DE (1) DE68905845T2 (fr)
DK (1) DK70289A (fr)
ES (1) ES2055036T3 (fr)
HU (1) HU202226B (fr)
IE (1) IE62645B1 (fr)
IL (1) IL89278A (fr)
MX (1) MX14957A (fr)
NZ (1) NZ227979A (fr)
PH (1) PH27562A (fr)
PT (1) PT89713B (fr)
RU (1) RU2015976C1 (fr)
ZA (1) ZA891113B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5238958A (en) * 1990-02-26 1993-08-24 Warner-Lambert Company Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals
ATE231505T1 (de) * 1991-03-28 2003-02-15 Eisai Co Ltd Neue heterocyclische/cyclische amine
CA2159326C (fr) * 1993-03-29 2000-05-30 Robert Kisilevsky Methode pour le traitement de l'amyloidose
US20040208875A1 (en) 1995-03-15 2004-10-21 Queen's University At Kingston Method for treating amyloidosis
US6022868A (en) * 1995-06-29 2000-02-08 Novo Nordisk Als Substituted azacyclic or azabicyclic compounds
US5880138A (en) * 1996-10-01 1999-03-09 Eli Lilly And Company NMDA receptor selective antagonists
US7056917B2 (en) 2001-04-26 2006-06-06 Daiichi Pharmaceutical Co., Ltd. Drug efflux pump inhibitor
US7244764B2 (en) 2003-06-23 2007-07-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US7414076B2 (en) 2003-06-23 2008-08-19 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases
US20070010573A1 (en) 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
US8044100B2 (en) 2004-12-22 2011-10-25 Bellus Health Inc. Methods and compositions for treating amyloid-related diseases
TW200716088A (en) 2005-04-15 2007-05-01 Neurochem Int Ltd Formulations and methods for treating amyloidosis
MX2008008213A (es) 2005-12-22 2008-09-03 Neurochem Int Ltd Tratamiento de trastornos renales, nefropatia diabetica y dislipidemias.
DK2089417T3 (en) 2006-10-12 2015-03-23 Bhi Ltd Partnership Methods, Compounds, Compositions and Vehicles for Delivery of 3-Amion-1-Propanesulfonic Acid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives
US4746653A (en) * 1986-02-28 1988-05-24 Ciba-Geigy Corporation Certain hetero phosphonic acid derivatives of 2-piperidine or 2-tetrahydropyridinecarboxylates and esters thereof which are useful for the treatment of disorders responsive to blockade of the NMDA receptor in mammals
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
US4968678A (en) * 1988-02-19 1990-11-06 Eli Lilly And Company Tetrazole excitatory amino acid receptor antagonists

Also Published As

Publication number Publication date
HUT49603A (en) 1989-10-30
IE62645B1 (en) 1995-02-22
JPH01249767A (ja) 1989-10-05
DE68905845T2 (de) 1993-08-05
ES2055036T3 (es) 1994-08-16
IL89278A (en) 1993-03-15
EP0330353B1 (fr) 1993-04-07
CA1332239C (fr) 1994-10-04
DE68905845D1 (de) 1993-05-13
MX14957A (es) 1993-11-01
AU608692B2 (en) 1991-04-11
RU2015976C1 (ru) 1994-07-15
PT89713A (pt) 1989-10-04
AU3009089A (en) 1989-08-24
ATE87918T1 (de) 1993-04-15
PH27562A (en) 1993-08-18
DK70289A (da) 1989-08-21
EP0330353A1 (fr) 1989-08-30
DK70289D0 (da) 1989-02-15
CN1022244C (zh) 1993-09-29
PT89713B (pt) 1994-04-29
IE890518L (en) 1989-08-19
HU202226B (en) 1991-02-28
IL89278A0 (en) 1989-09-10
NZ227979A (en) 1991-02-26
CN1035114A (zh) 1989-08-30

Similar Documents

Publication Publication Date Title
CA2009578A1 (fr) Antagonistes des recepteurs d'acide amine excitateur
IE902288L (en) Tetrazolylmethylpiperidine carboxylic acid
MY115977A (en) Synthetic excitatory amino acids
PH27562A (en) Tetrazole excitatory amino acid receptor antagonists
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
MY131442A (en) Excitatory amino acid receptor antagonists
NZ329627A (en) 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones
ZA949405B (en) Excitatory amino acid receptor antagonists
CS8708732A2 (en) Method of hv1, hv2, hv3 hirodin forms' one variant production
IL111580A0 (en) Melatonin derivatives for use in treating sleep disorders
GR3015297T3 (en) Improvements in and relating to serotonin antagonists.
CS473587A1 (en) Zpusob cisteni 1 amino 2,6 dimethylpiperidinu pripraveneho redukci 1 nitroso 2,6 dimethylpiperidinu